Prognostic value of left atrial function in systemic light-chain amyloidosis: A cardiac magnetic resonance study

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 9, 2016, Pages 961-969

  Mohty, Dania ^a,b   Boulogne, Cyrille ^a   Magne, Julien ^a   Varroud Vial, Nicolas ^c   Martin, Sylvain ^a   Ettaif, Hind ^a   Fadel, Bahaa M ^d   Bridoux, Frank ^c   Aboyans, Victor ^a   Damy, Thibaud ^e   Jaccard, Arnaud ^a,b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

AL amyloidosis; Cardiac magnetic resonance; Left atrial function; Prognosis

Indexed keywords

GADOTERATE MEGLUMINE; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; FEMALE; HEART AMYLOIDOSIS; HEART ATRIUM FUNCTION; HEART HEMODYNAMICS; HEART LEFT ATRIUM; HEART LEFT ATRIUM EMPTYING FRACTION; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; REPRODUCIBILITY; STAGING; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LIGHT CHAIN AMYLOIDOSIS; AGE; ANALYSIS OF VARIANCE; BLOOD; CARDIOMYOPATHY; CINE MAGNETIC RESONANCE IMAGING; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CONFIDENCE INTERVAL; DIAGNOSTIC IMAGING; FACTUAL DATABASE; FRANCE; HEART ATRIUM; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SURVIVAL ANALYSIS;

AGE FACTORS; AGED; AMYLOIDOSIS; ANALYSIS OF VARIANCE; CARDIOMYOPATHIES; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; FRANCE; HEART ATRIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOGLOBULIN LIGHT CHAINS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 84992036514     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jew100     Document Type: Article

References (29)

1. Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B et al. Al amyloidosis. Orphanet J Rare Dis 2012;7:54.
2. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-12.
3. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-7.
4. Klein AL, Hatle LK, Taliercio CP, Oh JK, Kyle RA, Gertz MA et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991;83:808-16.
5. Yang H,Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 2005;18:1074-82.
6. Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol 1988;11:757-68.
7. Hatle LK, Appleton CP, Popp RL. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography. Circulation 1989;79: 357-70.
8. Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343-9.
9. Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2009;2:1369-77.
10. Habibi M, Venkatesh BA, Lima JA. Feature tracking cardiac magnetic resonance imaging in the assessment of left atrial function. J Am Coll Cardiol 2014;63:2434-5.
11. Jarvinen VM, Kupari MM, Poutanen VP, Hekali PE. A simplified method for the determination of left atrial size and function using cine magnetic resonance imaging. Magn Reson Imaging 1996;14:215-26.
12. Gupta S, Matulevicius SA, Ayers CR, Berry JD, Patel PC, Markham DW et al. Left atrial structure and function and clinical outcomes in the general population. Eur Heart J 2013;34:278-85.
13. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR. Amyloidosis. Best Pract Res Clin Haematol 2005;18:709-27. Epub 2005/07/20.eng.
14. Gueret P, Joffre F. Guide de bonnes pratiques et recommandations en imagerie cardiaque en coupes. Arch Cardiovasc Dis 2009;1:1.
15. Posina K, McLaughlin J, Rhee P, Li L, Cheng J, SchapiroWet al. Relationship of phasic left atrial volume and emptying function to left ventricular filling pressure: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2013;15:99.
16. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc 2012;1:e000364.
17. Fitzgerald BT, Scalia GM, Cain PA, Garcia MJ, Thomas JD. Left atrial size-another differentiator for cardiac amyloidosis. Heart Lung Circ 2011;20:574-8.
18. Kwong RY, Heydari B, Abbasi S, Steel K, Al-Mallah M, Wu H et al. Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrastenhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function. Am J Cardiol 2015;116:622-9.
19. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995;92:835-41.
20. Zhuang J, Wang Y, Tang K, Li X, Peng W, Liang C et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace 2012;14:638-45.
21. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 2006;47:1018-23.
22. Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol 2014;63: 493-505.
23. Spethmann S, Stuer K, Diaz I, Althoff T, Hewing B, Baumann G et al. Left atrial mechanics predict the success of pulmonary vein isolation in patients with atrial fibrillation. J Interv Card Electrophysiol 2014;40:53-62.
24. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B et al. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol 2010;105: 1317-26.
25. Rossi L, Malagoli A, Piepoli M, Franchi F, Malavasi V, Casali E et al. Indexed maximal left atrial volume predicts response to cardiac resynchronization therapy. Int J Cardiol 2013;168:3629-33.
26. Bellavia D, Pellikka PA, Al-Zahrani GB, Abraham TP, Dispenzieri A, Miyazaki C et al. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 2010;23:643-52.
27. Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'FallonWMet al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992;79:1817-22.
28. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126:1206-16.
29. Karamitsos TD, Neubauer S. T1 mapping and amyloid cardiomyopathy: how much better can it get? Eur Heart J 2015;36:203-5.